Catalyst Wire Dossier Catalyst Wire Dossier

PCV13 candidate vaccine (PICTPCV13i)

· CanSino Biologics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCV13 candidate vaccine (PICTPCV13i), covering 2024-04-02 to 2024-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) [Phase 3]

See pricing